Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers

NCT02261103 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Pramipexole ER tablets
DRUG: Pramipexole IR tablets
DRUG: Placebo matching Pramipexole ER tablets
DRUG: Placebo matching Pramipexole IR tablets
OTHER: Standard high-fat breakfast

Sponsor

Boehringer Ingelheim